BIIB Operating Cash Flow (Statement)

Biogen · Operating Cash Flow (Statement)

BIIB logo

BIIB Operating Cash Flow (Statement)

Latest reported$2.88B
BIIB TTM Cash from Operations ($10.70M → $2.88B)
High-resolution chart · PNG

BIIB operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
2,878,800,000
2,590,800,000
2,204,600,000
2,453,600,000
2,116,700,000
2,581,600,000
2,875,500,000
2,127,100,000
1,783,900,000
1,645,100,000
1,547,200,000
1,359,700,000
1,428,300,000
1,677,800,000
1,384,300,000
2,397,600,000
2,541,900,000
3,032,700,000
3,639,900,000
2,434,500,000
2,810,300,000
3,531,500,000
4,229,800,000
6,557,100,000
7,070,900,000
7,086,400,000
7,078,600,000
7,013,800,000
7,054,800,000
6,190,100,000
6,187,700,000
5,810,600,000
5,703,000,000
5,772,900,000
4,551,000,000
4,609,300,000
3,967,600,000
3,794,200,000
4,522,400,000
3,986,195,000
3,895,043,000
3,946,463,000
3,716,100,000
3,608,568,000
3,627,153,000
3,570,526,000
2,942,115,000
2,878,257,000
2,636,146,000
2,270,765,000
2,345,078,000
1,983,980,000
1,853,842,000
1,864,211,000
1,879,897,000
1,845,964,000
1,874,703,000
1,668,788,000
1,727,741,000
1,684,823,000
1,542,541,000
1,541,356,000
1,624,673,000
1,475,789,000
1,310,973,000
1,111,043,000
1,074,898,000
1,202,018,000
1,450,786,000
1,498,257,000
1,564,492,000
1,501,062,000
1,199,295,000
1,125,291,000
1,020,635,000
916,578,000
965,990,000
947,344,000
841,268,000
874,203,000
787,460,000
832,870,000
889,503,000
806,324,000
812,138,000
742,911,000
727,986,000
603,548,000
522,490,000
410,003,000
288,089,000
320,445,000
289,294,000
281,795,000
267,077,000
224,652,000
245,037,000
288,333,000
316,358,000
434,136,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.